On November 27, 2018, the Board of Directors of Joway Health Industries Group Inc. appointed Jun Pang and Haibo Fan to the Board, both as independent directors under the New York Stock Exchange rules addressing director independence. Mr. Pang has more than 15 years of relevant experience. He is presently the Purchasing and Logistics Manager for Evonik Specialty Chemicals (Jilin) Co. Ltd., where he has served as such since 2013. Prior to transitioning to his current role, Mr. Pang served since 2004 as purchasing manager, and from 2004 to 2010 he was also logistics manager for BASF Petrochina Pentyl Glycol Co. Ltd. Mr. Fan also has more than 15 years of relevant experience. He is currently the financial controller for Jilin Petrochemical Co. Ltd. (“Jilin”), where he has served in that role since October 2007. On November 27, 2018, the Board formed a Special Committee and appointed both Messrs. Pang and Fan as its sole members to serve at the Board’s pleasure. The Special Committee was formed for the purpose of evaluating for fairness as to the Company and its shareholders certain proposed and alternative transactions not in the ordinary course of business that may from time to time arise. Recommendations about such transactions considered by the Special Committee must be submitted to the whole Board before the Board takes action with respect to any such proposed or alternative transaction. The Special Committee has wide discretion and may retain professional advisors to assist in its evaluations.